Target intelligence / Profile preview

Colonization of the gut

Molecular classification
Other (biological process, not a molecule or receptor)
01

Overview

"Colonization of the gut" refers to the **process** by which microorganisms—including bacteria, archaea, fungi, and viruses—establish themselves within the gastrointestinal tract. This process begins at or before birth and is influenced by factors such as delivery mode, diet, environment, host genetics, immune status, and exposure to antibiotics. The initial microbial community shapes later succession events; early facultative anaerobes pave the way for strict anaerobes that dominate adult microbiota composition[3][5]. Successful colonizers must overcome physiological barriers like bile acids and antimicrobial peptides as well as competition from other microbes[6]. The established gut microbiota performs essential functions including nutrient metabolism; synthesis of vitamins; training and modulation of host immunity; protection against pathogens via "colonization resistance"; maintenance of intestinal barrier integrity; and production of bioactive metabolites affecting distant organs. Disruption or abnormal patterns in this process are linked with increased susceptibility to infections (e.g., Clostridioides difficile), inflammatory diseases such as IBD, metabolic disorders like obesity/diabetes, allergies/autoimmunity risk in infants born via C-section or exposed early to antibiotics. "Colonization" itself is not a molecular target but rather a complex ecological phenomenon involving many microbial species interacting with each other and with host tissues through diverse molecular mechanisms.[1][3][5]

Other names
Gut colonizationMicrobial colonization of the gutIntestinal colonization
02

Biological functions

Establishment and maintenance of microbial communities in the gastrointestinal tractModulation of immune system development and function[1][3][4]Metabolism of dietary components[1][3]Protection against pathogen invasion (colonization resistance)[4][7]
03

Disease associations

Infection (role in susceptibility to enteric pathogens)[4][7]Inflammation (dysbiosis can contribute to inflammatory diseases)[1][4]Other (implicated in metabolic disorders, obesity, cancer risk through microbiome alterations)[1]
04

Safety considerations

Disruption by antibiotics leading to dysbiosis and increased infection risk[6]Potential for overgrowth by pathogenic species if normal colonization is impaired[4]

Beyond the preview

Go deeper on Colonization of the gut.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonization of the gut.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call